ClinicalTrials.Veeva

Menu

WithDRawal Impact Of Postoperative Beta-Blocker (DROP-BB)

Yale University logo

Yale University

Status

Terminated

Conditions

Coronary Artery Bypass

Treatments

Other: Discontinuing all beta-blocker

Study type

Interventional

Funder types

Other

Identifiers

NCT05414331
2000032771

Details and patient eligibility

About

The investigators will evaluate the impact of withdrawing beta-blocker medication after coronary artery bypass surgery with this randomized controlled trial.

Full description

Aim 1: The primary aim is to evaluate the impact of withdrawing BB on exercise capacity (peak oxygen consumption, VO2 max) in patients who underwent CABG. The investigators hypothesize that withdrawing BB 1 month after CABG will improve exercise capacity 2 months after CABG.

Aim 2: The secondary objectives are to evaluate the impact of withdrawing BB on a MACCE (major adverse cardiac and cerebrovascular event) and fatigue-related symptoms in patients who underwent CABG. The investigators hypothesize that withdrawing BB after CABG for 1 year will be non-inferior to continuing BB in terms of MACCE incidence.

Enrollment

43 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants who underwent coronary artery bypass graft(CABG) surgery at Yale New Haven Hospital who presented to 1-month postoperative visit
  • ejection fraction >50%, and in sinus rhythm at the time of hospital discharge or enrollment.

Exclusion criteria

  • those who underwent combined valve + CABG surgery or aorta + CABG surgery.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

43 participants in 2 patient groups

Continuation of beta-blocker regimen
No Intervention group
Description:
Participants will continue with current standard of care on current beta-blocker regimen
Withdrawing of beta-blockers
Experimental group
Description:
Discontinuation of all BB, and medication changes will be made at the 1-month clinic visit. A cardiopulmonary exercise test (CPET) will be performed 1 month after the randomization (2 months after CABG).
Treatment:
Other: Discontinuing all beta-blocker

Trial contacts and locations

1

Loading...

Central trial contact

Arnar Geirsson, MD; Makoto Mori, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems